GSK’s Oncology Portfolio in India to be Boosted by Jemperli and Zejula
GSK's India oncology portfolio is set to receive a significant boost with the introduction of…
GSK's India oncology portfolio is set to receive a significant boost with the introduction of…
Brazil and Nigeria are exploring a partnership to manufacture generic drugs, a move that could…
Akums Drugs has partnered with the Zambia government to supply medicines worth $50 million, with…
Halda Therapeutics and Vantai have partnered to develop AI-driven cancer treatments using induced proximity technology,…
Essex Bio Technology reports strong interim results, driven by innovative products and strategic partnerships, solidifying…
Fosun Pharma announces its 2025 interim results, showcasing a significant increase in revenue and profitability,…
The Massachusetts biopharma industry is sounding the alarm on a potential decline in US leadership,…
Abdera Therapeutics presents early pharmacokinetics, dosimetry, and safety data from ongoing Phase 1 trial of…
Debiopharm initiates first-in-human trial for Debio 1453, a novel antibiotic against gonorrhea, pushing innovation boundaries…
The global CAR-T cell therapy market is expected to reach $29 billion by 2029, driven…